Published on | 4 years ago
Programmes FET EIC PilotThe number of proposals that was submitted for the calls FETPROACT-EIC-07-2020 and FETPROACT-EIC-08-2020 was in total 236 - 149 proposals for 07 and 87 for 08 – of which 18 proposals are eligible for funding – 13 for 07 and 5 for 08. Under these 18 proposals are four with a Flemish partner:
An overview of the funded proposals, their consortium partners and allocated budgets
European Commission press release
Related news article
Number of proposals submitted - FETPROACT-EIC-07-2020 and FETPROACT-EIC-08-2020
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.